2017
Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, Heiken JP, Fowler KJ. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Radiology 2017, 286: 158-172. PMID: 28853673, DOI: 10.1148/radiol.2017170114.Peer-Reviewed Original ResearchConceptsNon-HCC malignanciesArterial phase hyperenhancementRim arterial phase hyperenhancementPositive predictive valueHepatocellular carcinomaPredictive valueData System (LI-RADS) version 2014Diagnostic performancePopulation of patientsHIPAA-compliant institutional review boardLiver Imaging ReportingLR-5 criteriaMalignant liver massesLI-RADS categoryFisher's exact testInstitutional review boardClinical followExtrahepatic malignanciesPathology findingsCommon findingLiver massExact testIndependent sample t-testMalignancyImaging ReportingTumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence
Olsen S, Jin L, Fields RC, Yan Y, Nalbantoglu I. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Human Pathology 2017, 68: 26-33. PMID: 28428104, DOI: 10.1016/j.humpath.2017.03.021.Peer-Reviewed Original ResearchConceptsIntestinal-type gastric adenocarcinomaHigher T stageIntestinal-type cancerGastric adenocarcinomaT stageNodal metastasisN stageLymph node statusSubset of patientsPrimary surgical excisionAmount of tumorCancer-related deathLikelihood of recurrenceDiffuse cancersBetter prognosisHistologic typePrognostic featuresSurgical excisionTumor buddingTumor characteristicsNode statusIntestinal tumorsClinical managementColorectal adenocarcinomaTumor grade
2016
Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential
Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Human Pathology 2016, 54: 143-151. PMID: 27090685, PMCID: PMC5242228, DOI: 10.1016/j.humpath.2016.03.018.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkers, TumorCell ProliferationClass I Phosphatidylinositol 3-KinasesDiagnosis, DifferentialDNA Mutational AnalysisFemaleGTP-Binding Protein alpha Subunits, Gq-G11Hemangioma, CavernousHemangiosarcomaHumansImmunohistochemistryKi-67 AntigenLiver NeoplasmsMaleMiddle AgedMutationNeoplasm GradingPhosphatidylinositol 3-KinasesPredictive Value of TestsProto-Oncogene Proteins c-mycTerminology as TopicTumor Suppressor Protein p53Vascular NeoplasmsYoung AdultConceptsHepatic small vessel neoplasmMalignant potentialCavernous hemangiomaVascular neoplasmImmunohistochemical stainsProliferative indexKi-67 proliferative indexTumour cell proliferative indexDisseminated intravascular coagulationKasabach-Merritt syndromePossible malignant potentialLow-grade tumorsUncertain malignant potentialRare vascular neoplasmCapture-based next-generation sequencingHistologic differential diagnosisCell proliferative indexC-myc stainingStrong p53Intravascular coagulationComplete resectionHepatic angiosarcomaDifferential diagnosisInfiltrative bordersAngiosarcoma
2015
Outcomes Using Grafts from Donors after Cardiac Death
Doyle MB, Collins K, Vachharajani N, Lowell JA, Shenoy S, Nalbantoglu I, Byrnes K, Garonzik-Wang J, Wellen J, Lin Y, Chapman WC. Outcomes Using Grafts from Donors after Cardiac Death. Journal Of The American College Of Surgeons 2015, 221: 142-152. PMID: 26095563, DOI: 10.1016/j.jamcollsurg.2015.03.053.Peer-Reviewed Original ResearchConceptsIschemic cholangiopathyPrimary nonfunctionRecipient ageLiver transplantationDonor graftsDCD donorsCardiac death liver graftsEnd-stage liver diseaseAdult liver transplantationDCD graft recipientsHepatic artery thrombosisAcute kidney injuryBrain-dead donorsLong-term outcomesWarm ischemia timeCold flushingDCD graftsDCD recipientsMedian ICUArtery thrombosisGraft survivalHospital stayKidney injuryRecipients of donationGraft recipientsIgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma
Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scandinavian Journal Of Gastroenterology 2015, 50: 447-453. PMID: 25635498, DOI: 10.3109/00365521.2014.962603.Peer-Reviewed Original ResearchConceptsIgG4-positive plasma cells/high-power fieldPlasma cells/high-power fieldHigh-power fieldCells/high power fieldAutoimmune pancreatitisExtrahepatic cholangiocarcinomaSclerosing cholangitisClinicopathological featuresBile duct injuryLymphoid follicle formationPrimary sclerosing cholangitisSecondary sclerosing cholangitisDense lymphoplasmacytic infiltrateEvidence of relapseExtrahepatic bile ductIgG4 serologyDuct injuryLymphoplasmacytic infiltrateRetroperitoneal fibrosisBenign courseBile ductPreoperative diagnosisCholangitisHigh percentageIgG4
2014
Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis.
Zhang C, Zhao Z, Osman H, Watson R, Nalbantoglu I, Lin J. Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. MicroRNA 2014, 3: 155-9. PMID: 25665881, DOI: 10.2174/2211536604666150209115444.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkersColitis, MicroscopicColitis, UlcerativeCrohn DiseaseFemaleHumansMaleMicroRNAsMiddle AgedConceptsIdiopathic inflammatory bowel diseaseMicroscopic colitisInflammatory bowel diseaseLymphocytic colitisCollagenous colitisMiR-31 expressionBowel diseaseMiR-31Colonic tissueSeparate disease processesMC episodesUlcerative colitisCrohn's diseaseExpression patternsColitisIntermittent episodesNormal controlsDisease processUseful biomarkerDifferential expressionPatientsColon tissuesDistinct entityDiseaseQRT-PCR